At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
At MAGI 2020, we spoke on the many advantages of 'going virtual.' Our presentation revolves around one critical observation: not every trial can go virtual, but every trial can benefit from implementing virtual elements. Virtual clinical trials make for happier, engaged patients who produce better data. Our patient-centric DCTs are evidence. View the presentation to learn more!
ObvioHealth recently completed the first-ever fully virtual urogynecology study to evaluate a medical digital intravaginal device for female stress urinary incontinence. In this randomized trial, pelvic floor muscle contractions were monitored.
Leveraging real-world examples from the first fully decentralized clinical trial in the urogynecology space, our presenters discuss the ways in which technology has helped to increase patient recruitment, engagement, and patient completion rates.
Despite the industry efforts to refine the processfor remote patient monitoring and outcomes measurement, accurate, complete real-worlddata is tough to capture. Our presentation offers insider industry knowledgegained from DCTs that employed next-gen ePRO and audio/image capture technologyto deliver reliable data sets.
